Advanced search
Publication Cover
Expert Opinion on Drug Delivery Volume 7, 2010 - Issue 10
Submit an article Journal homepage
386
Views
27
CrossRef citations to date
0
Altmetric
Reviews

Towards a targeted multi-drug delivery approach to improve therapeutic efficacy in breast cancer

Bin Wang Temple University, Department of Mechanical Engineering, 1947 North, 12th Street, Philadelphia, PA 19122, USA +1 215 204 3307; +1 215 204 4956; [email protected]
,
Jenna M Rosano Temple University, Department of Mechanical Engineering, 1947 North, 12th Street, Philadelphia, PA 19122, USA +1 215 204 3307; +1 215 204 4956; [email protected]
,
Rabe'e Cheheltani Temple University, Department of Mechanical Engineering, 1947 North, 12th Street, Philadelphia, PA 19122, USA +1 215 204 3307; +1 215 204 4956; [email protected]
,
Mohan P Achary Temple University School of Medicine, Department of Radiation Oncology, Philadelphia, PA 19140, USA
&
Mohammad F Kiani Temple University, Department of Mechanical Engineering, 1947 North, 12th Street, Philadelphia, PA 19122, USA +1 215 204 3307; +1 215 204 4956; [email protected]; Temple University School of Medicine, Department of Radiation Oncology, Philadelphia, PA 19140, USA
Pages 1159-1173 | Published online: 25 Aug 2010

Citations (27)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Qian Liu, Jixi Zhang, Wei Sun, Qian Reuben Xie, Weiliang Xia & Hongchen Gu. (2012) Delivering hydrophilic and hydrophobic chemotherapeutics simultaneously by magnetic mesoporous silica nanoparticles to inhibit cancer cells. International Journal of Nanomedicine 7, pages 999-1013.
Read now

Articles from other publishers (26)

Tracy Bouyon Yenda, Carine Jiguet-Jiglaire, Imene Khichane, Quentin Gobert, Rathinasabapathi Prabhakaran, Alexandre De Nonneville, Thierry Djenizian, Sébastien Salas & Frédéric Dallemer. (2022) Controlled Synthesis of Small Water-Soluble Hybrid Gold Nanoparticles: An Optimized Strategy for Stable Nano-Dispersion and Towards Cellular Uptake. Frontiers in Mechanical Engineering 8.
Crossref
Sepideh Ketabi, Forough Gholipour & Mohadeseh Naderi. (2021) Molecular Simulation Study of Gold Clusters for Transporting of Thioguanine Anticancer Drug in Aqueous Solution. Journal of Cluster Science 33:1, pages 135-143.
Crossref
Menghuan Li, Hui Zhang, Yanhua Hou, Xuan Wang, Chencheng Xue, Wei Li, Kaiyong Cai, Yanli Zhao & Zhong Luo. (2020) State-of-the-art iron-based nanozymes for biocatalytic tumor therapy. Nanoscale Horizons 5:2, pages 202-217.
Crossref
Mitra Korani, Solmaz Ghaffari, Hossein Attar, Mohammad Mashreghi & Mahmoud Reza Jaafari. (2019) Preparation and characterization of nanoliposomal bortezomib formulations and evaluation of their anti-cancer efficacy in mice bearing C26 colon carcinoma and B16F0 melanoma. Nanomedicine: Nanotechnology, Biology and Medicine 20, pages 102013.
Crossref
Nicholas Ekow ThomfordKevin DzoboEmile ChimusaKerstin Andrae-MarobelaShadreck ChirikureAmbroise WonkamCollet Dandara. (2018) Personalized Herbal Medicine? A Roadmap for Convergence of Herbal and Precision Medicine Biomarker Innovations. OMICS: A Journal of Integrative Biology 22:6, pages 375-391.
Crossref
Umme Ayesa, Brian D. Gray, Koon Y. Pak & Parkson Lee-Gau Chong. (2016) Liposomes Containing Lipid-Soluble Zn(II)–Bis-dipicolylamine Derivatives Show Potential To Be Targeted to Phosphatidylserine on the Surface of Cancer Cells. Molecular Pharmaceutics 14:1, pages 147-156.
Crossref
Shankar Suman, Trayambak Basak, Prachi Gupta, Sanjay Mishra, Vijay Kumar, Shantanu Sengupta & Yogeshwer Shukla. (2016) Quantitative proteomics revealed novel proteins associated with molecular subtypes of breast cancer. Journal of Proteomics 148, pages 183-193.
Crossref
Yuan Tang, Yue Wang, Mohammad F. Kiani & Bin Wang. (2016) Classification, Treatment Strategy, and Associated Drug Resistance in Breast Cancer. Clinical Breast Cancer 16:5, pages 335-343.
Crossref
Rutika R. Naik, Ting Luo, Mohammad Kohandel & Sharmila A. Bapat. (2016) Tumor deconstruction as a tool for advanced drug screening and repositioning. Pharmacological Research 111, pages 815-819.
Crossref
Kwaku Appiah-Kubi, Ying Wang, Hai Qian, Min Wu, Xiaoyuan Yao, Yan Wu & Yongchang Chen. (2016) Platelet-derived growth factor receptor/platelet-derived growth factor (PDGFR/PDGF) system is a prognostic and treatment response biomarker with multifarious therapeutic targets in cancers. Tumor Biology 37:8, pages 10053-10066.
Crossref
Buddhadev Layek, Tanmoy Sadhukha & Swayam Prabha. (2016) Glycoengineered mesenchymal stem cells as an enabling platform for two-step targeting of solid tumors. Biomaterials 88, pages 97-109.
Crossref
Girish Rai, Sanjay Mishra, Shankar Suman & Yogeshwer Shukla. (2016) Resveratrol improves the anticancer effects of doxorubicin in vitro and in vivo models: A mechanistic insight. Phytomedicine 23:3, pages 233-242.
Crossref
R R Naik, A K Singh, A M Mali, M F Khirade & S A Bapat. (2015) A tumor deconstruction platform identifies definitive end points in the evaluation of drug responses. Oncogene 35:6, pages 727-737.
Crossref
Taweewun Hunsawong, Panya Sunintaboon, Saradee Warit, Butsaya Thaisomboonsuk, Richard G. Jarman, In-Kyu Yoon, Sukathida Ubol & Stefan Fernandez. (2015) A novel dengue virus serotype-2 nanovaccine induces robust humoral and cell-mediated immunity in mice. Vaccine 33:14, pages 1702-1710.
Crossref
Ruirui Zhang, Yinghua Liu, Zhiwei Yang, Yunhao Li, Xianghui Rong, Lin Wang, Chujun Guo, Sheng Li, Junxing Liu, Mingjun Li & Yan Wu. (2015) Construction of nanoparticles based on amphiphilic PEI–PA polymers for bortezomib and paclitaxel co-delivery. RSC Advances 5:20, pages 15453-15460.
Crossref
C Xu, L Lin, G Cao, Q Chen, P Shou, Y Huang, Y Han, Y Wang & Y Shi. (2013) Interferon-α-secreting mesenchymal stem cells exert potent antitumor effect in vivo. Oncogene 33:42, pages 5047-5052.
Crossref
N. Sanoj Rejinold, Thejus Baby, K.P. Chennazhi & R. Jayakumar. (2014) Dual drug encapsulated thermo-sensitive fibrinogen-graft-poly (N-isopropyl acrylamide) nanogels for breast cancer therapy. Colloids and Surfaces B: Biointerfaces 114, pages 209-217.
Crossref
Tai-Long Pan, Pei-Wen Wang, Yu-Chiang Hung, Chun-Hsun Huang & Kun-Ming Rau. (2013) Proteomic analysis reveals tanshinone IIA enhances apoptosis of advanced cervix carcinoma CaSki cells through mitochondria intrinsic and endoplasmic reticulum stress pathways. PROTEOMICS 13:23-24, pages 3411-3423.
Crossref
STEFAN LANGHAMMER. (2013) Rationale for the design of an oncology trial using a generic targeted therapy multi-drug regimen for NSCLC patients without treatment options (Review). Oncology Reports 30:4, pages 1535-1541.
Crossref
Gary Gellerman, Sophia Baskin, Luboshits Galia, Yosef Gilad & Michael A. Firer. (2013) Drug resistance to chlorambucil in murine B-cell leukemic cells is overcome by its conjugation to a targeting peptide. Anti-Cancer Drugs 24:2, pages 112-119.
Crossref
A. Bridoux, S.A. Mousa & M.-M. Samama. (2012) Pro- and anti-angiogenic agents. Journal des Maladies Vasculaires 37:3, pages 132-139.
Crossref
Leonor Munoz Alcivar & Yashwant Pathak. 2012. Antibody-Mediated Drug Delivery Systems. Antibody-Mediated Drug Delivery Systems 35 55 .
M. Pons-Salort, B. van der Sanden, A. Juhem, A. Popov & A. Stéphanou. (2012) A Computational Framework to Assess the Efficacy of Cytotoxic Molecules and Vascular Disrupting Agents against Solid Tumours. Mathematical Modelling of Natural Phenomena 7:1, pages 49-77.
Crossref
Coralie Deladriere, Rut Lucas & María J. Vicent. 2011. Drug Delivery in Oncology. Drug Delivery in Oncology 805 837 .
Lee Sleightholm, Ajit Zambre, Nripen Chanda, Zahra Afrasiabi, Kattesh Katti & Raghuraman Kannan. (2011) New nanomedicine approaches using gold–thioguanine nanoconjugates as metallo-ligands. Inorganica Chimica Acta 372:1, pages 333-339.
Crossref
Naito Kurio, Tsuyoshi Shimo, Takuya Fukazawa, Munenori Takaoka, Tatsuo Okui, Nur Mohammad Monsur Hassan, Tatsuki Honami, Shinji Hatakeyama, Masahiko Ikeda, Yoshio Naomoto & Akira Sasaki. (2011) Anti-tumor effect in human breast cancer by TAE226, a dual inhibitor for FAK and IGF-IR in vitro and in vivo. Experimental Cell Research 317:8, pages 1134-1146.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.